{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:09:16Z","timestamp":1765714156063,"version":"3.48.0"},"reference-count":20,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1992,6]]},"abstract":"<jats:p>AIMS: To determine if there are type specific differences in serum antibody responses to synthetic peptides derived from human papillomavirus (HPV) open reading frame (ORF) E2 in patients with cervical carcinoma. METHODS: Diagnostic phase sera from 88 age-matched women with cervical adenocarcinoma (AC), cervical squamous cell carcinoma (SC), ovarian cancer (OC) or no gynaecological malignancy were available. Serum IgG and IgA antibodies to synthetic peptides corresponding to a residue of HPV 6, 11, 16, and 18 ORF E2 18 amino acids long and a control peptide from mumps virus were determined by ELISA. RESULTS: Both IgA and IgG antibody positivity to the HPV 18 peptide were associated with increased risk (9.0-fold, confidence limits 1.5-199) for AC. IgA positivity to HPV 11, 16, and 18 peptides was associated with an increased risk for SC. However, the association of IgG antibodies to HPV 16 peptide with SC was not significant. IgA or IgG antibodies to HPV 6 or mumps virus peptides were not associated with increased risk for AC, SC, or OC. CONCLUSIONS: These results suggest a specific role for HPV 18 in AC. Differences in antibody responses to HPV peptide in AC and SC suggest immunopathogenetic differences between the two types of cervical carcinoma.<\/jats:p>","DOI":"10.1136\/jcp.45.6.494","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"494-497","source":"Crossref","is-referenced-by-count":11,"title":["Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma."],"prefix":"10.1136","volume":"45","author":[{"given":"M","family":"Lehtinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Leminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Paavonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Lehtovirta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hy\u00f6ty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Vesterinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1992,6,1]]},"reference":[{"key":"ref_1","first-page":"\"1","article-title":"Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence","volume":"57","author":"Munoz, N.; Bosh, X.; Kaldor, J.M.","year":"1988","unstructured":"Munoz N, Bosh X, Kaldor JM. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer 1988;57:1-5. 2 zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-81.","journal-title":"Br J Cancer; zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers"},{"key":"ref_2","first-page":"13","article-title":"HPV typing of cervical adenocarcinomas by PCR","volume":"1989","author":"Cone, R.; Beckman, A.; Galloway, D.; Paavonen, J.","unstructured":"Cone R, Beckman A, Galloway D, Paavonen J. HPV typing of cervical adenocarcinomas by PCR. J Cell Biochem 1989;(suppl 13)C:183.","journal-title":"J Cell Biochem"},{"key":"ref_3","first-page":"639","article-title":"Histogenesis of cervical adenocarcinoma with reference of human papillomavirus-18 as a carcinogen","volume":"34","author":"Okakagi, T.; Tase, T.; Twiggs, L.B.; Carlson, L.","year":"1989","unstructured":"Okakagi T, Tase T, Twiggs LB, Carlson L. Histogenesis of cervical adenocarcinoma with reference of human papillomavirus-18 as a carcinogen. J Reprod Med 1989; 34:639-44","journal-title":"J Reprod Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcp\/95.5.647","article-title":"Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix","volume":"95","author":"Leminen, A.; Paavonen, J.; Vesterinen, E.","year":"1991","unstructured":"Leminen A, Paavonen J, Vesterinen E, et al. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991;95:647-52.","journal-title":"Am J Clin Pathol"},{"key":"ref_5","first-page":"3838","article-title":"A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed","volume-title":"virus-carrying cervical neoplasia. Proc Natl Acad Sci","volume":"86","author":"Dillner, J.; Dillner, L.; Robb, J.","year":"1989","unstructured":"Dillner J, Dillner L, Robb J, et al. A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci USA 1989;86: 3838-41."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ijc.2910460426","article-title":"Mapping of linear epitope oftissue papilloma virus type 16: the El, E2, E4, E5, E6 and E7 open reading frames","volume":"46","author":"Dillner, J.","year":"1990","unstructured":"Dillner J. Mapping of linear epitope oftissue papilloma virus type 16: the El, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer 1990;46:703-1 1.","journal-title":"Int J Cancer"},{"key":"ref_7","first-page":"682","article-title":"Occurrence of antibodies to LI, L2, E4, and E7 gene products of human papillomavirus types 6b, 16, and 18 among cervical cancer patients and controls","volume":"48","author":"Kochel, H.G.; Monazahian, M.; Sievert, K.","year":"1991","unstructured":"Kochel HG, Monazahian M, Sievert K, et al. Occurrence of antibodies to LI, L2, E4, and E7 gene products of human papillomavirus types 6b, 16, and 18 among cervical cancer patients and controls. Int J Cancer 1991;48:682-8. Peptides of HPV 18 ORF E2 in cervical carcinoma","journal-title":"Int J Cancer; Peptides of HPV 18 ORF E2 in cervical carcinoma"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0042-6822(85)90214-4","article-title":"Human papillomavirus type 16 DNA sequence","volume":"145","author":"Seedorf, K.; Krammer, G.; Durst, M.","year":"1985","unstructured":"Seedorf K, Krammer G, Durst M, et al. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5.","journal-title":"Virology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/j.1460-2075.1983.tb01744.x","article-title":"DNA sequence and genome organization of genital human papillomavirus type 6b","volume":"12","author":"Schwarz, E.; Durst, M.; Demankowski, C.","year":"1983","unstructured":"Schwarz E, Durst M, Demankowski C, et al. DNA sequence and genome organization of genital human papillomavirus type 6b. Eur Mol Biol Org J 1983;12:2341-8.","journal-title":"Eur Mol Biol Org J"},{"key":"ref_10","first-page":"124","article-title":"The nucleotide sequence and genome organization of human papillomavirus type 1 1","volume":"151","author":"Dartman, K.; Schwarz, E.; Gissman, L.; zur Hausen, H.","year":"1986","unstructured":"Dartman K, Schwarz E, Gissman L, zur Hausen H. The nucleotide sequence and genome organization of human papillomavirus type 1 1. Virology 1986;151:124-30."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0022-2836(87)90343-3","article-title":"Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of E6 and E7 gene products","volume":"193","author":"Cole, ST, Danos 0","year":"1987","unstructured":"Cole ST, Danos 0. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of E6 and E7 gene products. J Mol Biol 1987;193:599-608.","journal-title":"J Mol Biol"},{"key":"ref_12","first-page":"1239","article-title":"Humoral immunity against viral antigen in insulin dependent diabetes mellitus: altered IgA class immune response against mumps virus. Clin Exp Immunol","volume":"60","author":"Hyoty, H.; Huupponen, T.; Leinikki, P.","year":"1985","unstructured":"Hyoty H, Huupponen T, Leinikki P. Humoral immunity against viral antigen in insulin dependent diabetes mellitus: altered IgA class immune response against mumps virus. Clin Exp Immunol 1985;60:1239-44."},{"key":"ref_13","article-title":"Statistical methods in cancer research. The analysis of case control studies","volume":"32","author":"Breslow, N.; Day, N.","year":"1990","unstructured":"Breslow N, Day N. Statistical methods in cancer research. The analysis of case control studies. IARC Scientific Publication no 32. Lyon: IARC, 1990.","journal-title":"IARC Scientific Publication"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jcp.44.4.340","article-title":"Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridization","volume":"44","author":"Young, F.I.; Ward, L.M.; Brown, L.J.R.","year":"1991","unstructured":"Young FI, Ward LM, Brown LJR. Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridization. J Clin Pathol 1991;44:340-1.","journal-title":"J Clin Pathol"},{"key":"ref_15","first-page":"7815","article-title":"Occurrence of IgG and IgA antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls","volume":"50","author":"Mann, V.M.; DeLao, S.L.; Brenes, M.","year":"1990","unstructured":"Mann VM, DeLao SL, Brenes M, et al. Occurrence of IgG and IgA antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res 1990;50:7815-9.","journal-title":"Cancer Res"},{"key":"ref_16","first-page":"1183","article-title":"Topography ofearly HPV 16 transcription in high-grade genital precancers","volume":"134","author":"Crum, C.P.; Sympula, M.; Ward, B.E.","year":"1989","unstructured":"Crum CP, Sympula M, Ward BE. Topography ofearly HPV 16 transcription in high-grade genital precancers. Am J Pathol 1989;134:1183-8.","journal-title":"Am J Pathol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/JVI.62.2.606-609.1988","article-title":"Identification of the human papillomavirus E2 protein in genital tract tissues","volume":"62","author":"H, Li C.-C.; RV, Gilden; SD, Showalter; KV, Shah","year":"1988","unstructured":"Li C-C H, Gilden RV, Showalter SD, Shah KV. Identification of the human papillomavirus E2 protein in genital tract tissues. J Virol 1988;62:606-9.","journal-title":"J Virol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/JVI.65.2.606-612.1991","article-title":"Analysis of the physical stage of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasias","volume":"65","author":"Cullen, A.P.; Reid, R.; Campion, M.; Lorincz, A.T.","year":"1991","unstructured":"Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical stage of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasias. J Virol 1991;65:606-12.","journal-title":"J Virol"},{"key":"ref_19","first-page":"1","article-title":"Gene expression of HPV types 16 and 18 in cervical neoplasia","volume":"124","author":"Stoler, M.; Rodes, C.; Whitbeck, A.","year":"1990","unstructured":"Stoler M, Rodes C, Whitbeck A, et al. Gene expression of HPV types 16 and 18 in cervical neoplasia. UCLA Mol Cell Biol 1990;124:1-1 1.","journal-title":"UCLA Mol Cell Biol"},{"key":"ref_20","first-page":"439","article-title":"Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies","volume":"66","author":"Biggard, R.J.; Nkrumah, F.K.; Henle, W.; Levine, P.H.","year":"1981","unstructured":"Biggard RJ, Nkrumah FK, Henle W, Levine PH. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies. JNCI 1981;66:439-44.","journal-title":"JNCI"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.45.6.494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:05:52Z","timestamp":1765713952000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.45.6.494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1992,6,1]]},"published-print":{"date-parts":[[1992,6]]}},"alternative-id":["10.1136\/jcp.45.6.494"],"URL":"https:\/\/doi.org\/10.1136\/jcp.45.6.494","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}